Inflammatory Hypothesis Confirmed: Reducing Inflammation Without Lowering Cholesterol Cuts Risk of Cardiovascular Events
Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events
Source: BWH News - Category: Hospital Management Source Type: news
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Heart | Hospital Management